Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' updated ALDG2 assay helps with the evaluation of patients with suspected autoimmune liver disease. The panel also helps with the evaluation of liver disease of unknown etiology.

Speaker 2: (00:32)
 Could you provide a little bit about you and your background?

Speaker 2: (02:05)
 Can you please give a brief overview of this assay?

Speaker 2: (04:12)
 Which patients should have this testing and when should it be performed? 

Speaker 2: (07:17)
 Could you please go into detail about the changes we've made in this test?

Speaker 2: (11:46)
 How are the results used in patient care?